Are drugs designed to work best for all patients?
Are randomised controlled trials achieving the results we need for patients? In the latest instalment of ERS Vision, Professor Elisabeth Bel leads a discussion on the relevance of real-life evidence and whether it can enhance existing guidelines.
The documentary considers how we can ask the right questions to provide the right solutions for each individual patient. Leading experts consider the value of this type of research, along with the issues surrounding quality standards, costs and how it can be effectively designed and applied.
European Respiratory Society: Should we be testing new drugs in the ‘real’ world where some patients smoke, are obese and have other comorbidities?
Share this post
Latest News posts
Why is social distancing so important?
April 6, 2020
Covert infections and the spread of coronavirus
March 24, 2020
Do I Have Coronavirus?
March 19, 2020
Seasonal Viral Epidemics & COVID-19
March 18, 2020
Asthma and Covid 19 – research findings
March 17, 2020
Notice for National Aspergillosis Centre Patients
March 13, 2020
Coronavirus (COVID-19) Social distancing introduced
March 2, 2020
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video